Chinese Journal of Mycology 2010, Vol. 5 Issue (5): 312-315,320.
Previous Articles Next Articles
Received:2010-05-24
Online:2010-10-28
Published:2010-10-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/
http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/Y2010/V5/I5/312
| [1] 桑红,廖万清,陈江汉,等.新生隐球菌产黑素野生株和白化突变株的比较研究[J].中华皮肤科杂志,2000,33(5):347-348. [2] Maxson ME,Cook E,Casadevall A,et al.The volume and hydration of the Cryptococcus neoformans polysacchatide capsule[J].Fungal Genet Biol,2007,44(3):180-186. [3] Jesus MD,Nicola AM,Rodrigues ML,et al.Capsular localization of the Cryptococcus neoformans polysaccharide component galactexylomannan[J].Eukaryot Cell,2009,8(1):96-103. [4] Franzot SP,Salkin IF,Casadevall A.Cryptococcus neoformans var.grubii:separate varietal status for Cryptococcus neoformans serotype A isolates[J].J Clin Microbiol,1999,37(3):838-840. [5] Okabayashi K,Kano R,Watanabo S,et al.Expression of capsule-associated genes of Cryptococcus neoformans[J].Mycopathologia,2005,160(1):1-7. [6] Rodrigues ML,Nakayasu ES,Oliveira DL,et al.Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence[J].Eukatyot Cell,2008,7(1):58-67. [7] Klutts JS,Levery SB,Doering TL.A beta-1,2-xylesyhransferase from Cryptococcus neoformans defines a new family of glycosyl-transferases[J].J Biol Chem,2007,282(24):17890-17899. [8] 潘炜华,廖万清,刘晓刚,等.绿色荧光蛋白GFP基因与新生隐球菌荚膜基因的融合表达系统[J].中国真菌学杂志,2006,1(4):193-196. [9] Bar-Peled M,Griffith CL,Ory JJ,et al.Biosynthesis of UDPGIcA,a key metabolite for capsular polyzaccharide synthesis in the pathogenic fungus Cryptococcus neoformans[J].Biochem J,2004,381(pt1):131-136. [10] Griffith CL,Klutts JS,Zhang L,et al.UDP-glucoso dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans[J].J Biol Chem,2004,279(49):51669-51676. [11] Moyrand F,Fontaine T,Janbon G.Systematic capsule gone disruption reveals the central role of galactese metabolism on Cryptococcus neoformans virulence[J].Mol Micrebiol,2007,64(3):771-781. [12] Nimrichter L,Frases S,Cinelli LP,et al.Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations[J].Eukaryot Cell,2007,6(8):1400-1410. [13] O 'Meata TR,Norton D,Price MS,et al.Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule[J].PLoS Pathog,2010,6(2):e1000776:1-14. [14] Yaneda A,Doering TL.A eukaryotic eapsalar polysaccharide is synthesized intracellularly and secreted via exocytosis[J].Mol Biol Cell,2006,17(12):5131-5140. [15] Rodrigues ML,Nakayasu ES,Oliveira DL,et al.Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence[J].Eukaryot Cell,2008,7(1):58-67. [16] Nicola AM,Frases S,Casadevall A.Lipophilic dye staining of Cryptococcus neoformans extracellular vesicles and capsule[J].Eukaryot Call,2009,8(9):1373-1380. [17] Taborda CP,Casadevall A.CR3(CD11b/CD18)and CR4(CD11c/CD18)are involved in complement-independent antibody-mediated phagocytesis of Cryptococcus neoformans[J].Immunity,2002,16(6):791-802. [18] Gates MA,Kozel TR.Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans[J].Infect Immun,2006,74(6):3096-3106. [19] Botts MR,Giles SS,Gates MA,et al.Isolation and characterization of Cryptococcus neoformans spores reveal a critical role for capsule biosynthesis genes in spore biogenesis[J].Eukaryot Cell,2009,8(4):595-605. [20] Barbosa FM,Fonseca FL,Figeeiredo RT,et al.Binding of glucuronoxylomannan to the CD14 receptor in human A549 alveolar cells induces intedeukin-8 preduction[J].Clin Vaccine Immunol,2007,14(1):94-98. [21] Shea JM,Kechichian TB,Luberto C,et al.The cryptococcal enzyme inositolphosphosphingolipid-phespholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system[J].Infect Immun,2006,74(10):5977-5988. [22] Moyzand F,Fontaine T,Janbon G.Systematic capsule gone disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence[J].Mol Microbiol,2007,64(3):771-781. [23] Monari C,Bistoni F,Vecchiatelli A.Glueuronoxylomannan exhibits potent immunesuppressive properties[J].FEMS Yeast Res,2006,6(4):537-542. [24] Villena SN,Pinheiro BO,Pinheiro CS,et al.Capsular polyzaccharides galactoxylomannan and glucaronoxylomannan from Cryptococcus neoformans induce macrophage apoptesis mediated by Fas ligand[J].Cell Microbiol,2008,10(6):1274-1285. [25] Walenkamp AM,Chaka WS,Verheul AF,et al.Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclcar cells despite differences in struture[J].FEMS Immunol Med Microbiol,1999,26(34):309-318. [26] Cleare W,Mukherjee S,Spitzer ED,et al.Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies[J].Clin Diagn Lab Immunol,1994,1(6):737-740. [27] Larsen RA,Pappas PG,Perfect J,et al.Phase Ⅰ evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18 B7 in subjects with treated cryptecoccal meningitis[J].Antimicrob Agents Chemother,2005,49(3):952-958. [28] Rivera J,Casadevall A.Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against Cryptococcus neoformans[J].J Immunol,2005,174(12):8017-8026. [29] Beeubouwer DO,Shapiro S,Feldmesser M,et al.Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans[J].Infect Immun,2001,69(10):6445-6455. [30] Taborda CP,Rivera J,Zaragoza O,et al.More is not necessarily better:prozone-like effects in passive immunization with IgG[J].J Immunol,2003,170(7):3621-3630. [31] Detta K,Lees A,Pirofski L.Therapeutic efficacy of a conjugate vaccine containing a peptide mimotopo of cryptecoccal capsular polysaccharide glucuronoxylomannan[J].Clin Vaccine Immunol,2008,15(8):1176-1187. |
| [1] | ZHU Xin-lin, HONG Nan, ZHANG Chao, PAN Wei-hua, CAI Liang-qi, LI Xiao-jing, CHEN Min, LIAO Wan-qing. Genotypic diversity of 11 Cryptococcus neoformans isolates from kidney transplantation patients with cryptococcosis [J]. Chinese Journal of Mycology, 2020, 15(6): 338-343. |
| [2] | ZHAO Jing-yu, LIU Yi-shu, FANG Wei, LIAO Wan-qing, WANG Gui-zhen, GU Ju-lin. Construction and identification of yeast two-hybrid cDNA library of Cryptococcus neoformans [J]. Chinese Journal of Mycology, 2020, 15(3): 134-137. |
| [3] | HUANG Jin-bao, LI Hong-yan, LAN Chang-qing, LV Xiao, LIN Zhi-lai, WANG Xin-hang, ZHANG Hong-ying, ZOU Sheng-hua, WEN Heng. Clinical application and evaluation oftwo different methods for detection of cryptococcal capsular polysaccharide antigen in diagnosis and treatment of pulmonary cryptococcosis [J]. Chinese Journal of Mycology, 2019, 14(5): 264-269. |
| [4] | LAI Rui, SONG Ying, LIU Wei-you, YUAN Xiao-liang. Improvement of the purification method of cryptococcal capsular polysaccharide glucuronoxylomannan [J]. Chinese Journal of Mycology, 2019, 14(4): 228-231. |
| [5] | LEI Yan, FANG Wei, ZHANG Chao, LIAO Wan-qing. In vitro chessboard detection for anti-Cryptococcus effect of rattlerin and fluconazole [J]. Chinese Journal of Mycology, 2019, 14(2): 90-94. |
| [6] | DENG Dong-ling, KONG Qing-tao, ZHANG Yuan-yuan, YUAN Hong-shan, LIU Hui, SANG Hong. Prokaryotic expression of Cryptococcus neoformans laccase [J]. Chinese Journal of Mycology, 2018, 13(4): 208-212. |
| [7] | CHEN Yan-hui, YU Feng, BIAN Ze-yuan, HONG Jian-ming, ZHONG Qiao-shi, HANG Ya-ping, ZHANG Nan, HU Long-hua. Molecular epidemiology and clinical characteristics of 34 cases of cryptococcal infection in HIV patients [J]. Chinese Journal of Mycology, 2018, 13(3): 152-157. |
| [8] | . [J]. Chinese Journal of Mycology, 2017, 12(4): 244-247,256. |
| [9] | LI Ying-Fang, SANG Jun-Jun, LI Juan, JIANG Wei-Wei, LIAO Wan-Qing, PAN Wei-Hua. Effects of transforming growth factor on the function of macrophage against Cryptococcus neoformans [J]. Chinese Journal of Mycology, 2017, 12(2): 65-68. |
| [10] | Yultuz·Xohrat, Kadirye·Kasim, WANG Xiao-dong, DENG Shu-wen, Prida·Abliz. Molecular identification and genotyping and in vitro drug sensitivity study of the first five clinical isolates of Cryptococcus neoformans in Xinjiang [J]. Chinese Journal of Mycology, 2016, 11(6): 327-331. |
| [11] | ZHENG Chong, WEN Hai, GUO Fang, FAN Yi-bin. The study of expression changes of VEGFR in mice brain tissue infected with Cryptococcus neoformans [J]. Chinese Journal of Mycology, 2016, 11(5): 257-260. |
| [12] | QIU Tian wen, ZHU Hong-mei, WEN Hai. Cryptococcus traversal across the Blood-Brain Barrier though S100A10-dependent activation of urokinase-plasmin system [J]. Chinese Journal of Mycology, 2016, 11(3): 129-134. |
| [13] | LI Ying-fang, PAN Wei-hua. Pattern regcognition receptors and signaling pathways in Cryptococcus neoformans [J]. Chinese Journal of Mycology, 2016, 11(1): 58-61. |
| [14] | ZHOU Zhao-jing, FANG Wei, PAN Wei-hua, LIAO Wan-qing. Effect of mandelic acid and its metabolism made on virulence of Cryptococcus neoformans [J]. Chinese Journal of Mycology, 2015, 10(6): 328-331. |
| [15] | GUO Lan-fang, LIU Da-biao, ZHOU Meng-jie, HUA Teng-jiang. The effects of tetrandrine on Candida albicans biofilm and germ tube formation [J]. Chinese Journal of Mycology, 2015, 10(5): 276-278. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
